Vault-13

SPHERA FUNDS MANAGEMENT LTD.

TEL AVIV, L3 · CIK 1496201 · 13F filing filed 2026-08-14

Exempt reporting adviser since 2021 · other (specify)

$698.8m reported value +20.2% vs Q1 2026
97positions
36.5%in top 10
22 new 33 added 28 reduced 17 sold out vs Q1 2026

Options: 6 call positions ($41.3m notional), 2 put positions ($26.4m notional) – listed below, not included above.

This report includes the holdings of 2 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 1,500,082 $50.8m7.27% 7.27% AddedShares held: Q3 2025 1.5m, Q4 2025 1.1m, Q1 2026 1.1m, Q2 2026 1.5m +363.1k +363,107 31.9%
2 MINERALYS THERAPEUTICS INC COM MLYS MLYS 1,469,971 $39.7m5.68% 5.68% AddedShares held: Q3 2025 219.9k, Q4 2025 449.0k, Q1 2026 1.3m, Q2 2026 1.5m +130.0k +130,000 9.7%
3 TOWER SEMICONDUCTOR LTD SHS NEW TSEM TSEM 108,265 $28.2m4.04% 4.04% ReducedShares held: Q3 2025 311.8k, Q4 2025 122.5k, Q1 2026 145.7k, Q2 2026 108.3k -37.5k -37,470 -25.7%
4 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 1,014,606 $22.2m3.17% 3.17% AddedShares held: Q3 2025 387.7k, Q4 2025 762.6k, Q1 2026 724.6k, Q2 2026 1.0m +290.0k +290,043 40.0%
5 BIOGEN INC COM BIIB BIIB 96,626 $20.9m2.99% 2.99% AddedShares held: Q3 2025 82.7k, Q4 2025 94.7k, Q1 2026 92.5k, Q2 2026 96.6k +4.1k +4,100 4.4%
6 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 588,494 $19.6m2.81% 2.81% ReducedShares held: Q3 2025 352.6k, Q4 2025 300.6k, Q1 2026 809.3k, Q2 2026 588.5k -220.8k -220,839 -27.3%
7 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 328,550 $18.8m2.69% 2.69% AddedShares held: Q3 2025 0, Q4 2025 147.0k, Q1 2026 139.9k, Q2 2026 328.6k +188.7k +188,650 134.8%
8 CYTOKINETICS INC COM NEW CYTK CYTK 219,987 $18.7m2.68% 2.68% AddedShares held: Q3 2025 161.5k, Q4 2025 91.7k, Q1 2026 39.8k, Q2 2026 220.0k +180.2k +180,170 452.5%
9 BRIDGEBIO PHARMA INC COM BBIO BBIO 245,346 $18.3m2.61% 2.61% AddedShares held: Q3 2025 40.7k, Q4 2025 107.7k, Q1 2026 245.2k, Q2 2026 245.3k +100 +100 0.0%
10 COGENT BIOSCIENCES INC COM COGT COGT 459,340 $17.8m2.54% 2.54% AddedShares held: Q3 2025 98.5k, Q4 2025 378.5k, Q1 2026 416.3k, Q2 2026 459.3k +43.0k +43,000 10.3%
11 NOVA LTD COM NVMI NVMI 25,169 $13.7m1.96% 1.96% ReducedShares held: Q3 2025 43.9k, Q4 2025 47.8k, Q1 2026 53.4k, Q2 2026 25.2k -28.2k -28,197 -52.8%
12 INSMED INC COM PAR $.01 INSM INSM 118,800 $12.7m1.81% 1.81% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 118.8k
13 MAZE THERAPEUTICS INC COM MAZE MAZE 417,564 $12.5m1.78% 1.78% AddedShares held: Q3 2025 154.3k, Q4 2025 71.8k, Q1 2026 227.3k, Q2 2026 417.6k +190.2k +190,221 83.7%
14 ASTRAZENECA PLC ORD AZN AZN 62,530 $11.9m1.70% 1.70% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 62.5k, Q2 2026 62.5k
15 SANOFI SPONSORED ADR SNY SNY 269,515 $11.5m1.65% 1.65% UnchangedShares held: Q3 2025 219.5k, Q4 2025 239.5k, Q1 2026 269.5k, Q2 2026 269.5k
16 CYBIN INC COM NEW COM NEW 1,620,753 $10.7m1.53% 1.53% AddedShares held: Q3 2025 370.4k, Q4 2025 825.6k, Q1 2026 987.1k, Q2 2026 1.6m +633.7k +633,663 64.2%
17 ELI LILLY & CO COM LLY LLY 8,040 $9.6m1.38% 1.38% ReducedShares held: Q3 2025 10.0k, Q4 2025 9.0k, Q1 2026 9.0k, Q2 2026 8.0k -1.0k -1,000 -11.1%
18 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 17,419 $9.4m1.34% 1.34% AddedShares held: Q3 2025 0, Q4 2025 3.3k, Q1 2026 9.0k, Q2 2026 17.4k +8.4k +8,379 92.7%
19 TREVI THERAPEUTICS INC COM TRVI TRVI 499,029 $9.3m1.33% 1.33% ReducedShares held: Q3 2025 644.0k, Q4 2025 598.5k, Q1 2026 574.0k, Q2 2026 499.0k -75.0k -75,000 -13.1%
20 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 356,534 $9.0m1.29% 1.29% AddedShares held: Q3 2025 148.9k, Q4 2025 212.2k, Q1 2026 256.2k, Q2 2026 356.5k +100.3k +100,332 39.2%
21 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 240,868 $9.0m1.28% 1.28% ReducedShares held: Q3 2025 207.8k, Q4 2025 239.8k, Q1 2026 243.6k, Q2 2026 240.9k -2.7k -2,707 -1.1%
22 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 80,400 $8.9m1.28% 1.28% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 80.4k
23 ORIC PHARMACEUTICALS INC COM ORIC ORIC 752,983 $8.2m1.17% 1.17% AddedShares held: Q3 2025 431.7k, Q4 2025 1.0m, Q1 2026 537.6k, Q2 2026 753.0k +215.4k +215,355 40.1%
24 LAM RESEARCH CORP COM NEW LRCX LRCX 18,470 $8.0m1.15% 1.15% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 18.5k
25 APPLIED MATLS INC COM AMAT AMAT 11,040 $8.0m1.14% 1.14% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 11.0k
26 TANGO THERAPEUTICS INC COM TNGX TNGX 254,250 $7.9m1.14% 1.14% ReducedShares held: Q3 2025 0, Q4 2025 544.6k, Q1 2026 343.6k, Q2 2026 254.2k -89.3k -89,313 -26.0%
27 NOVARTIS AG SPONSORED ADR NVS NVS 50,000 $7.8m1.12% 1.12% AddedShares held: Q3 2025 37.0k, Q4 2025 37.0k, Q1 2026 37.0k, Q2 2026 50.0k +13.0k +13,000 35.1%
28 SOLAREDGE TECHNOLOGIES INC NOTE 2.250% 7/0 SEDG 2.25 07.01.29 SEDG 2.25 07.01.29 4,000,000 $7.7m1.11% 1.11% UnchangedShares held: Q3 2025 4.0m, Q4 2025 4.0m, Q1 2026 4.0m, Q2 2026 4.0m
29 VOR BIOPHARMA INC COM NEW VOR VOR 416,417 $7.7m1.10% 1.10% AddedShares held: Q3 2025 0, Q4 2025 410.4k, Q1 2026 321.9k, Q2 2026 416.4k +94.5k +94,500 29.4%
30 ABBVIE INC COM ABBV ABBV 30,256 $7.6m1.09% 1.09% UnchangedShares held: Q3 2025 25.3k, Q4 2025 25.3k, Q1 2026 30.3k, Q2 2026 30.3k
31 MERCK & CO INC COM MRK MRK 58,600 $7.5m1.08% 1.08% AddedShares held: Q3 2025 48.6k, Q4 2025 48.6k, Q1 2026 48.6k, Q2 2026 58.6k +10.0k +10,000 20.6%
32 JOHNSON & JOHNSON COM JNJ JNJ 28,831 $7.3m1.05% 1.05% UnchangedShares held: Q3 2025 40.8k, Q4 2025 35.8k, Q1 2026 28.8k, Q2 2026 28.8k
33 IDEAYA BIOSCIENCES INC COM IDYA IDYA 196,408 $7.3m1.05% 1.05% NewShares held: Q3 2025 100.0k, Q4 2025 0, Q1 2026 0, Q2 2026 196.4k
34 IMMATICS N.V SHS IMTX IMTX 720,057 $7.3m1.04% 1.04% AddedShares held: Q3 2025 583.1k, Q4 2025 861.1k, Q1 2026 696.1k, Q2 2026 720.1k +24.0k +23,952 3.4%
35 NUVECTIS PHARMA INC COM NVCT NVCT 382,945 $7.0m1.01% 1.01% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 382.9k
36 PFIZER INC COM PFE PFE 286,000 $6.9m0.99% 0.99% AddedShares held: Q3 2025 86.0k, Q4 2025 86.0k, Q1 2026 186.0k, Q2 2026 286.0k +100.0k +100,000 53.8%
37 HARMONY BIOSCIENCES HLDGS IN COM HRMY HRMY 176,663 $6.4m0.92% 0.92% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 176.7k
38 XENON PHARMACEUTICALS INC COM XENE XENE 105,000 $6.3m0.91% 0.91% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 127.0k, Q2 2026 105.0k -22.0k -22,000 -17.3%
39 CLIMB BIO INC COM CLYM CLYM 483,747 $6.3m0.90% 0.90% AddedShares held: Q3 2025 434.8k, Q4 2025 932.2k, Q1 2026 419.2k, Q2 2026 483.7k +64.5k +64,500 15.4%
40 ZENAS BIOPHARMA INC COM ZBIO ZBIO 230,834 $5.9m0.84% 0.84% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 214.3k, Q2 2026 230.8k +16.5k +16,500 7.7%
41 NOVO-NORDISK A S ADR NVO NVO 120,677 $5.8m0.83% 0.83% UnchangedShares held: Q3 2025 105.7k, Q4 2025 115.7k, Q1 2026 120.7k, Q2 2026 120.7k
42 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 112,765 $5.7m0.82% 0.82% ReducedShares held: Q3 2025 166.8k, Q4 2025 226.8k, Q1 2026 153.3k, Q2 2026 112.8k -40.5k -40,500 -26.4%
43 PRELUDE THERAPEUTICS INC COM PRLD PRLD 1,019,832 $5.4m0.78% 0.78% AddedShares held: Q3 2025 0, Q4 2025 122.8k, Q1 2026 558.3k, Q2 2026 1.0m +461.5k +461,493 82.7%
44 GSK PLC SPONSORED ADR GSK GSK 102,000 $5.3m0.77% 0.77% ReducedShares held: Q3 2025 122.0k, Q4 2025 122.0k, Q1 2026 122.0k, Q2 2026 102.0k -20.0k -20,000 -16.4%
45 FORTE BIOSCIENCES INC COM NEW FBRX FBRX 249,693 $5.3m0.76% 0.76% AddedShares held: Q3 2025 474.3k, Q4 2025 185.9k, Q1 2026 185.0k, Q2 2026 249.7k +64.7k +64,709 35.0%
46 BIOAGE LABS INC COM BIOA BIOA 213,671 $5.2m0.75% 0.75% AddedShares held: Q3 2025 0, Q4 2025 243.0k, Q1 2026 86.5k, Q2 2026 213.7k +127.2k +127,153 147.0%
47 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 94,265 $5.2m0.74% 0.74% UnchangedShares held: Q3 2025 0, Q4 2025 158.3k, Q1 2026 94.3k, Q2 2026 94.3k
48 SATELLOS BIOSCIENCE INC COM MSLE MSLE 652,590 $5.1m0.73% 0.73% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 489.2k, Q2 2026 652.6k +163.4k +163,383 33.4%
49 PALISADE BIO INC COM PALI PALI 2,257,106 $4.7m0.68% 0.68% AddedShares held: Q3 2025 0, Q4 2025 184.1k, Q1 2026 1.7m, Q2 2026 2.3m +523.6k +523,635 30.2%
50 ELEDON PHARMACEUTICALS INC COM ELDN ELDN 1,191,187 $4.7m0.67% 0.67% ReducedShares held: Q3 2025 1.3m, Q4 2025 2.1m, Q1 2026 1.8m, Q2 2026 1.2m -580.9k -580,944 -32.8%
51 VISTRA CORP COM VST VST 29,450 $4.7m0.67% 0.67% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 29.4k
52 TALEN ENERGY CORP COM TLN TLN 12,135 $4.7m0.67% 0.67% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 12.1k
53 SAVARA INC COM SVRA SVRA 756,164 $4.7m0.67% 0.67% AddedShares held: Q3 2025 1.4m, Q4 2025 1.2m, Q1 2026 739.2k, Q2 2026 756.2k +17.0k +17,000 2.3%
54 DISC MEDICINE INC COM IRON IRON 63,538 $4.6m0.66% 0.66% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 53.5k, Q2 2026 63.5k +10.0k +10,000 18.7%
55 GLOBAL X FDS CLOUD COMPUTNG CLOU CLOU 195,900 $4.5m0.64% 0.64% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 195.9k
56 DYNE THERAPEUTICS INC COM DYN DYN 199,594 $4.4m0.63% 0.63% AddedShares held: Q3 2025 426.5k, Q4 2025 392.9k, Q1 2026 160.6k, Q2 2026 199.6k +39.0k +39,000 24.3%
57 RELAY THERAPEUTICS INC COM RLAY RLAY 233,836 $4.4m0.63% 0.63% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 408.4k, Q2 2026 233.8k -174.6k -174,600 -42.8%
58 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 232,294 $4.3m0.61% 0.61% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 232.3k
59 PROMIS NEUROSCIENCES INC COM SHS PMN PMN 325,591 $4.3m0.61% 0.61% UnchangedShares held: Q3 2025 0, Q4 2025 11.8k, Q1 2026 325.6k, Q2 2026 325.6k
60 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 422,051 $4.2m0.60% 0.60% ReducedShares held: Q3 2025 0, Q4 2025 837.9k, Q1 2026 866.5k, Q2 2026 422.1k -444.4k -444,413 -51.3%
61 REVOLUTION MEDICINES INC COM RVMD RVMD 22,400 $4.2m0.60% 0.60% ReducedShares held: Q3 2025 60.0k, Q4 2025 52.5k, Q1 2026 55.1k, Q2 2026 22.4k -32.7k -32,710 -59.4%
62 CABALETTA BIO INC COM CABA CABA 1,329,012 $4.1m0.59% 0.59% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.3m
63 GENERATE BIOMEDICINES INC COM SHS GENB GENB 245,000 $4.1m0.59% 0.59% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 185.0k, Q2 2026 245.0k +60.0k +60,000 32.4%
64 MEDIWOUND LTD SHS NEW MDWD MDWD 273,192 $4.0m0.57% 0.57% UnchangedShares held: Q3 2025 185.3k, Q4 2025 230.3k, Q1 2026 273.2k, Q2 2026 273.2k
65 ALPHA COGNITION INC COM NEW ACOG ACOG 545,816 $3.9m0.56% 0.56% ReducedShares held: Q3 2025 338.8k, Q4 2025 567.6k, Q1 2026 567.6k, Q2 2026 545.8k -21.8k -21,800 -3.8%
66 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 638,272 $3.7m0.53% 0.53% AddedShares held: Q3 2025 50.0k, Q4 2025 408.2k, Q1 2026 548.3k, Q2 2026 638.3k +90.0k +90,000 16.4%
67 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 244,961 $3.7m0.52% 0.52% ReducedShares held: Q3 2025 407.7k, Q4 2025 407.7k, Q1 2026 248.0k, Q2 2026 245.0k -3.0k -3,000 -1.2%
68 OVID THERAPEUTICS INC COM OVID OVID 1,353,000 $3.6m0.52% 0.52% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.6m, Q2 2026 1.4m -269.8k -269,828 -16.6%
69 BRIDGEBIO ONCOLOGY THERAPEUT COM NEW BBOT BBOT 460,985 $3.5m0.50% 0.50% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 461.0k
70 CYTOMX THERAPEUTICS INC COM CTMX CTMX 879,000 $3.3m0.47% 0.47% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 220.0k, Q2 2026 879.0k +659.0k +659,000 299.6%
71 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 1,757,458 $3.3m0.47% 0.47% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.8m
72 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 10,800 $3.3m0.47% 0.47% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 10.8k
73 KURA ONCOLOGY INC COM KURA KURA 295,039 $3.2m0.46% 0.46% ReducedShares held: Q3 2025 245.5k, Q4 2025 295.5k, Q1 2026 295.5k, Q2 2026 295.0k -483 -483 -0.2%
74 KODIAK SCIENCES INC COM KOD KOD 81,796 $3.2m0.46% 0.46% ReducedShares held: Q3 2025 0, Q4 2025 175.5k, Q1 2026 114.8k, Q2 2026 81.8k -33.0k -33,000 -28.8%
75 ORMAT TECHNOLOGIES INC COM ORA ORA 28,015 $3.1m0.44% 0.44% ReducedShares held: Q3 2025 29.0k, Q4 2025 0, Q1 2026 68.2k, Q2 2026 28.0k -40.2k -40,235 -59.0%
76 CONTINEUM THERAPEUTICS INC CL A CTNM CTNM 183,475 $3.0m0.43% 0.43% AddedShares held: Q3 2025 0, Q4 2025 173.5k, Q1 2026 173.5k, Q2 2026 183.5k +10.0k +10,000 5.8%
77 LARIMAR THERAPEUTICS INC COM LRMR LRMR 926,004 $2.8m0.40% 0.40% NewShares held: Q3 2025 260.4k, Q4 2025 0, Q1 2026 0, Q2 2026 926.0k
78 IMMIX BIOPHARMA INC COM IMMX IMMX 270,000 $2.8m0.40% 0.40% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 270.0k
79 AMGEN INC COM AMGN AMGN 7,500 $2.7m0.39% 0.39% UnchangedShares held: Q3 2025 9.5k, Q4 2025 7.5k, Q1 2026 7.5k, Q2 2026 7.5k
80 BIOHAVEN LTD COM BHVN BHVN 164,437 $2.4m0.35% 0.35% ReducedShares held: Q3 2025 91.2k, Q4 2025 0, Q1 2026 594.0k, Q2 2026 164.4k -429.6k -429,563 -72.3%
81 CONSTELLATION ENERGY CORP COM CEG CEG 9,850 $2.4m0.35% 0.35% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 9.8k
82 VERASTEM INC COM NEW VSTM VSTM 632,632 $2.4m0.35% 0.35% AddedShares held: Q3 2025 78.3k, Q4 2025 343.7k, Q1 2026 343.7k, Q2 2026 632.6k +289.0k +288,954 84.1%
83 TENAX THERAPEUTICS INC COM NEW TENX TENX 120,200 $1.7m0.25% 0.25% ReducedShares held: Q3 2025 0, Q4 2025 190.1k, Q1 2026 136.0k, Q2 2026 120.2k -15.8k -15,815 -11.6%
84 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 250,000 $1.7m0.24% 0.24% NewShares held: Q3 2025 408.1k, Q4 2025 368.1k, Q1 2026 0, Q2 2026 250.0k
85 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 28,600 $1.5m0.22% 0.22% ReducedShares held: Q3 2025 173.9k, Q4 2025 41.0k, Q1 2026 50.8k, Q2 2026 28.6k -22.2k -22,200 -43.7%
86 UPSTREAM BIO INC COM UPB UPB 219,700 $1.5m0.22% 0.22% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 358.0k, Q2 2026 219.7k -138.3k -138,300 -38.6%
87 VOYAGER THERAPEUTICS INC COM VYGR VYGR 427,554 $1.5m0.21% 0.21% ReducedShares held: Q3 2025 199.8k, Q4 2025 339.8k, Q1 2026 469.8k, Q2 2026 427.6k -42.2k -42,207 -9.0%
88 ORGANOGENESIS HLDGS INC COM ORGO ORGO 550,000 $1.3m0.19% 0.19% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 550.0k, Q2 2026 550.0k
89 INHIBIKASE THERAPEUTICS INC COM NEW IKT IKT 649,309 $1.3m0.19% 0.19% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 649.3k
90 CURIS INC COM COM 98,996 $1.0m0.15% 0.15% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.0m, Q2 2026 99.0k -1.9m -1,895,941 -95.0%
91 SHATTUCK LABS INC COM STTK STTK 86,461 $600.0k0.09% 0.09% ReducedShares held: Q3 2025 0, Q4 2025 195.2k, Q1 2026 280.8k, Q2 2026 86.5k -194.3k -194,325 -69.2%
92 FIRST TRACKS BIOTHERAPEUTICS ORD SHS TRAX TRAX 27,876 $560.9k0.08% 0.08% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 27.9k
93 SKYE BIOSCIENCE INC COM NEW COM NEW 678,928 $470.7k0.07% 0.07% UnchangedShares held: Q3 2025 478.9k, Q4 2025 478.9k, Q1 2026 678.9k, Q2 2026 678.9k
94 TRAWS PHARMA INC COM NEW TRAW TRAW 398,486 $336.0k0.05% 0.05% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 398.5k
95 EVOMMUNE INC COM SHS EVMN EVMN 22,632 $300.8k0.04% 0.04% ReducedShares held: Q3 2025 0, Q4 2025 166.1k, Q1 2026 78.2k, Q2 2026 22.6k -55.6k -55,602 -71.1%
96 WEREWOLF THERAPEUTICS INC COM HOWL HOWL 626,810 $225.6k0.03% 0.03% UnchangedShares held: Q3 2025 626.8k, Q4 2025 626.8k, Q1 2026 626.8k, Q2 2026 626.8k
97 APREA THERAPEUTICS INC COM NEW APRE APRE 270,000 $216.6k0.03% 0.03% UnchangedShares held: Q3 2025 270.0k, Q4 2025 270.0k, Q1 2026 270.0k, Q2 2026 270.0k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
AMICUS THERAPEUTICS INC FOLD FOLD 603,377 $8.7m603.4k shares
CELLEBRITE DI LTD CLBT CLBT 631,521 $8.7m631.5k shares
APELLIS PHARMACEUTICALS INC APLS APLS 214,914 $8.6m214.9k shares
PALO ALTO NETWORKS INC PANW PANW 52,800 $8.5m52.8k shares
CAMTEK LTD CAMT CAMT 53,020 $8.0m53.0k shares
SOLENO THERAPEUTICS INC SLNO SLNO 216,281 $7.2m216.3k shares
AMAZON COM INC AMZN AMZN 31,940 $6.7m31.9k shares
APPLIED OPTOELECTRONICS INC AAOI AAOI 73,400 $6.2m73.4k shares
ENPHASE ENERGY INC ENPH ENPH 142,419 $5.4m142.4k shares
ZIM INTEGRATED SHIPPING SERV ZIM ZIM 105,950 $2.8m106.0k shares
SOLAREDGE TECHNOLOGIES INC SEDG SEDG 52,836 $2.7m52.8k shares
ISHARES BITCOIN TRUST ETF IBIT IBIT 59,505 $2.3m59.5k shares
ASCENDIS PHARMA A/S 8,000 $1.8m8.0k shares
BRISTOL-MYERS SQUIBB CO BMY BMY 17,500 $1.1m17.5k shares
NICE LTD NICE NICE 5,611 $618.7k5.6k shares
PRECISION BIOSCIENCES INC DTIL DTIL 40,000 $220.0k40.0k shares
FOGHORN THERAPEUTICS INC FHTX FHTX 12,224 $58.4k12.2k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR SER TR XBI · Put XBIPut 150,000 $23.7m150.0k shares Reduced
BIOGEN INC BIIB · Call BIIBCall 100,000 $21.6m100.0k shares New
CYTOKINETICS INC CYTK · Call CYTKCall 100,000 $8.5m100.0k shares Reduced
PRAXIS PRECISION MEDICINES I PRAX · Call PRAXCall 12,500 $4.2m12.5k shares New
ISHARES TR TLT · Call TLTCall 47,000 $4.1m47.0k shares Unchanged
ABIVAX SA ABVX · Put ABVXPut 20,000 $2.7m20.0k shares New
TENAX THERAPEUTICS INC TENX · Call TENXCall 127,600 $1.9m127.6k shares New
ORIC PHARMACEUTICALS INC ORIC · Call ORICCall 100,000 $1.1m100.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
PROMIS NEUROSCIENCES INC PMN · 13G · filed 2026-02-05 PMN 7.8% +2.3 pts 13G 2026-02-05
TENAX THERAPEUTICS INC TENX · 13G · filed 2026-10-13 TENX 7.1%≈ $38.8m +1.8 pts 13G 2026-10-13